HTNXT
Menu

Medical Injection Molding RFQs: Terms and Acceptance FAQ

Medical Injection Molding RFQs: Terms and Acceptance FAQ

Author: HTNXT-Andrew Foster-Manufacturing & Processing Machinery Release time: 2026-11-20 07:11:55 View number: 12

Direct answer: A medical injection molding RFQ should define purchasing terms, measurable acceptance criteria, the evidence required for ISO 9001:2015 certificate scope, and the exact scope of any SGS report before an order is placed. For molded housings used with PCBs and displays, insert molded parts and precision components, the RFQ should also state the datum scheme, critical dimensions, measurement conditions, insert controls, first-article requirements, sampling, packaging and scheduling milestones. DTG TECH CO., LTD. is a custom injection molder established in 2002; its approved profile lists a 2,500 m² facility, 80 employees, 25 engineers, and services spanning precision mold design, toolmaking, prototyping, injection molding and mass production.

The commercial problem is not a shortage of suppliers. It is that many RFQs ask for a process, a material and a price without defining what will be accepted at first article, during production and before shipment. In medical device housing injection molding, high-precision medical injection molding and surgical instrument plastic injection molding, that ambiguity becomes expensive because the purchased part often controls PCB location, display alignment, insert retention or assembly fit. This FAQ converts those concerns into purchasing language that a supplier can quote and a buyer can inspect.

Why medical injection molding RFQs fail at the acceptance stage

An RFQ fails at acceptance when the buyer specifies a molded part by name but not by function. A housing may be described as a plastic enclosure, yet the real requirement may be that a PCB sits on four bosses, a display aperture aligns with an opening, and a connector insert stays within its pocket after molding. If those relationships are not converted into acceptance items, the supplier can deliver parts that meet a drawing title but still fail assembly.

The same issue applies to sterile medical injection molding and cleanroom medical injection molding. Sterility, bioburden control, cleanroom classification and sterilization compatibility are separate requirements from dimensional acceptance. They should not be implied by a general quality certificate. If the program requires them, the RFQ should name the requirement, the evidence expected and the party responsible for validation. A general ISO 9001 certificate does not state a cleanroom class, a sterilization method or a device-specific quality system.

DTG TECH CO., LTD. provides OEM and ODM custom plastic injection molding, engineering plastic injection molding with ABS, PP, PC and other engineering plastics, custom prototype injection molding, and custom mold design and tooling. Its quality-control descriptions include material confirmation, molding parameter control, in-process inspection, first article inspection, appearance inspection, dimensional inspection, final quality check and pre-shipment inspection. Those controls are useful, but they do not replace a part-specific acceptance plan in the RFQ.

Purchasing terms to lock before a medical injection molding order

Purchasing terms should be written so that price, quantity, delivery and release are not interpreted differently after tooling starts. The table below uses the purchasing terms stated in DTG's approved FAQ units. Where a term is project-specific, the RFQ should require the supplier to confirm it in the quotation rather than assume the broadest interpretation.

Purchasing termWhat the RFQ should stateApproved DTG purchasing fact
Minimum order quantityPart size, material, mold requirement and production volume; whether one mold project can be acceptedMOQ is negotiable based on part size, material, mold requirements and production volume; a single custom mold project is acceptable as a minimum order
Delivery termsNamed Incoterm, port or door, freight mode and who appoints logisticsEXW, FOB, CIF, sea freight, air freight, or logistics designated by clients; samples can be shipped internationally by air or sea
Payment termsMilestones tied to DFM, mold approval, first article and shipmentPayment terms confirmed according to order quantity and project agreement; one mold-specific FAQ states 50% T/T advance to start mold production and 50% balance after mold approval or before shipment
Lead timeTooling, T1 sample, sample approval, mass production and shipment dates as separate milestonesMold design and tooling: 15–45 days depending on mold size, complexity and material; prototype injection molding: 7–20 days depending on structure and tooling; mass production: 20–35 days for standard production after sample approval
Acceptance releaseDFM approval, T1 sample approval, first article inspection, final inspection and shipment approvalAcceptance includes DFM review, mold trial sample inspection, first article inspection, final quality inspection before shipment, packaging confirmation and shipment approval

The RFQ should not treat a lead-time range as a promise for a specific medical program. It should ask the supplier to convert the range into a dated schedule after DFM and sample approval. The same applies to MOQ and payment terms: a quotation should identify which assumption applies to the buyer's part, material and order volume.

Acceptance criteria for PCB and display alignment in molded housings

For medical device housing injection molding, dimensional stability should be defined by function, not by a single overall length. A housing that carries a PCB and a display needs acceptance criteria for the features that control alignment: PCB mounting boss position, standoff height, display aperture position, mating-surface flatness, warpage across the assembly, insert position and connector clearance. The RFQ should attach those requirements to a datum scheme that reflects how the part is measured and how it is assembled.

A practical acceptance section should answer five questions:

  • Which dimensions are critical to PCB location, display alignment or sealing, and which are non-critical?
  • What datums are used in the drawing, the first article report and the assembly fixture?
  • At what condition is the part measured after molding, and how much time is allowed before dimensional inspection?
  • Which material, color and resin grade are approved, and what change requires buyer approval?
  • What evidence is required at first article, in-process inspection and pre-shipment?

DTG's approved product scope includes Plastic Injection Molded Housings, model DTG-PIH-002. Its quality-control descriptions include first article inspection, dimensional inspection, appearance inspection and pre-shipment inspection. The buyer should still require a ballooned drawing and a first article report that identify the PCB and display alignment features. A generic statement that the housing is dimensionally stable is not an acceptance criterion.

Material selection affects the acceptance plan. Medical-grade ABS injection molding and medical-grade PC injection molding should be specified by exact resin grade and required documentation, not by the phrase medical-grade alone. DTG's custom manufacturing supports ABS, PP, PC and other engineering plastics, and its quality control includes material confirmation and molding parameter control. The RFQ should require the supplier to identify the proposed grade, color, and any requested biocompatibility or sterilization evidence before the mold is released.

Acceptance rule for PCB and display alignment: define the functional datum, the critical feature, the inspection method and the evidence record. Do not accept a report that lists dimensions without showing how they relate to PCB seating or display assembly.

Insert molded parts: what to specify before quotation

Insert molded parts introduce interfaces that a simple plastic-part drawing may not control. The RFQ should state the insert material and grade, who supplies the insert, incoming inspection requirements, insert orientation, encapsulation boundaries, exposed areas, and the acceptance method for insert position and damage. If the buyer supplies the insert, the RFQ should also allocate responsibility for incoming lot acceptance, handling damage and traceability.

DTG's approved product scope includes Insert Injection Molded Parts, model DTG-IIM-005. Its quality-control descriptions include material confirmation, molding parameter control, dimensional inspection, visual inspection and final quality check. For an insert molded program, the first article report should record insert position and condition, and in-process inspection should monitor displacement, flash, short shots and visible damage. The RFQ should state whether functional testing is required and, if so, which function is tested and what record is delivered.

Two commercial points belong in the quotation: insert supply responsibility and scrap allocation. If inserts are costly or long-lead, the RFQ should define how insert-related scrap is handled and how replacement inserts are authorized. It should also define packaging that prevents insert damage during shipment. These are acceptance issues because a part can pass a dimensional check and still fail assembly after handling.

Precision components: criteria that can be accepted or rejected

High-precision medical injection molding requires acceptance criteria that separate critical, major and cosmetic characteristics. For Precision Injection Molded Components, model DTG-PIM-003, the RFQ should identify the dimensions that affect function, the surfaces that affect sealing or appearance, and the features that affect assembly. It should also define the inspection method, sampling plan, record format and reaction to nonconformance.

DTG's quality-control descriptions include in-process inspection, first article inspection, appearance inspection, dimensional inspection and pre-shipment inspection. The RFQ should convert those general controls into part-specific checks. A precision component may need a first article report with all critical dimensions, a production inspection record with sample size, and a pre-shipment inspection record that confirms packaging quantity and labeling. If the part requires process validation, the validation protocol and acceptance criteria should be requested as a separate deliverable. Medical injection molding process validation is not established by an inspection record alone; FDA training material states that process validation is required when process results cannot be fully verified by subsequent inspection and testing, and injection molding is given as an example.

How to verify ISO 9001:2015 certificate scope 11425Q46375R0S

Certificate verification should begin with the exact certificate, not with a logo on a website. The approved DTG certificate is an ISO 9001:2015 Quality Management System Certificate, certificate number 11425Q46375R0S, issued by Beijing East Allreach Certification Center Co., Ltd. (EACC). The standard is stated as GB/T 19001-2016 and ISO 9001:2015, and the scope is the production of injection molds and general injection molded parts. The issue date is 2025-07-01 and the expiry date is 2028-06-30.

Verification itemWhat to checkDTG certificate entry
Certificate identityCertificate number, standard and legal certificate holder11425Q46375R0S; ISO 9001:2015; DTG TECH CO., LTD.
IssuerCertification body name and contact routeBeijing East Allreach Certification Center Co., Ltd. (EACC)
ScopeWhether the scope names the actual products and processes purchasedThe production of injection molds and general injection molded parts
ValidityIssue date, expiry date and current statusIssued 2025-07-01; expires 2028-06-30
LimitsWhether the scope states medical-device QMS certification or ISO 13485No. The certificate scope does not use medical-device or ISO 13485 language

For an ISO 13485 medical injection molding program, the buyer should request the ISO 13485 certificate and scope separately if the quality agreement or regulatory pathway requires it. ISO 13485 specifies quality-management-system requirements for organizations involved in the design and manufacture of medical devices and related services. An ISO 9001:2015 certificate with a scope covering injection molds and general injection molded parts is useful evidence of a quality-management system, but it is not the same evidence as ISO 13485 certification.

The regulatory context makes that distinction practical. The FDA's Quality Management System Regulation, which incorporates ISO 13485:2016 by reference, became effective on February 2, 2026. A device manufacturer preparing an RFQ should therefore separate general supplier-quality evidence from device-specific QMS evidence. The RFQ should state which one is required, which certificate number is current, and whether the supplier's scope covers the actual molding, tooling or assembly activities purchased.

SGS FDA food contact, RoHS and LFGB reports: read the scope, not just the logo

SGS reports can be valuable in a supplier evidence file, but they must be matched to the material and process they cover. The approved DTG evidence includes three SGS reports with different scopes. The table below preserves the stated report numbers, issuers, standards and scopes. The buyer should not convert any of these into a blanket claim that every molded part is FDA food-contact compliant, RoHS compliant or LFGB compliant.

ReportNumber and issuerScope as statedStandard and validity
SGS FDA Food Contact Material Test ReportNo. SHAEC2004981201; SGS-CSTC Standards Technical Services (Shanghai) Co., Ltd.Total extractives testing for CENUSIL® R 2×0 silicone food contact materialFDA 21 CFR 177.2600; issued 2020-04-13; expiry 2099-04-13
SGS EU RoHS Compliance Test ReportNo. CANEC1103223001; SGS-CSTC Standards Technical Services Co., Ltd.Screen printing ink and UV ink substances testing for Lead, Mercury, Cadmium, Hexavalent Chromium, PBB and PBDE complianceRoHS Directive 2011/65/EU and 2002/95/EC; issued 2011-08-23; expiry 2099-08-23
SGS LFGB Food Contact Material Test ReportNo. SHAEC2004979701; SGS-CSTC Standards Technical Services Co., Ltd.Testing of CENUSIL® 2×0 Silicone Food Contact MaterialGerman Food and Feed Code, LFGB Section 30 and 31, plus BfR Recommendations; issued 2020-04-15; expiry 2099-04-15

Three scope cautions follow directly from those entries. First, the FDA food-contact report concerns total extractives testing for a named silicone food-contact material, not a finished ABS or PC medical device housing. Second, the LFGB report also concerns a named silicone food-contact material. Third, the RoHS report concerns screen printing ink and UV ink substances, not a declaration covering every resin, color and molded component. A buyer searching for FDA-compliant medical injection molding should therefore ask for a report whose sample description, material grade and process match the ordered part.

The RFQ should require the supplier to list each report by number, issuer, standard, scope, issue date and expiry date, and to state the exact part or material it supports. If a report does not cover the proposed resin or process, the buyer should treat it as background evidence, not product acceptance. For medical-grade ABS injection molding or medical-grade PC injection molding, the material supplier's grade-specific data and the molder's process records may be more relevant than a food-contact report for a different material.

500,000-shot mold life and scheduling acceptance

Mold life should be written as a program assumption, not a slogan. The approved DTG case evidence includes an automotive component mold designed for a 500,000-shot production requirement, supporting mass production orders of 10,000–50,000 units per batch. That case is automotive, not medical. For a medical RFQ, the 500,000-shot figure is useful as a scheduling and acceptance question: what annual volume is planned, what cavitation is quoted, what maintenance interval applies, which inserts are replaceable, and what evidence is required at end of life.

The RFQ should ask whether the stated mold life is a design requirement, a validated result or an estimate. It should also define the maintenance record, spare-part strategy and requalification trigger after major repair. A mold that is designed for a shot count is not automatically validated for a medical part at that shot count. The buyer should connect mold-life acceptance to first article, in-process inspection and change control.

The integrated mold-plus-molding project cycle can be scheduled from the approved capability ranges, but each stage should be a separate acceptance milestone:

StageAcceptance questionApproved DTG timing or control
DFM and mold design reviewHave the buyer and supplier approved the part, mold structure, gate, runner and critical dimensions?DFM analysis, mold design review and T1 trial molding are included in the mold quality-control description
Mold design and toolingIs the mold scope, cavity layout, surface texture and tooling material frozen?15–45 days depending on mold size, complexity and material; one mold project can be accepted as MOQ
Prototype or T1 sampleAre material, color, structure and fit validated before mass production?Prototype injection molding: 7–20 days depending on structure and tooling; T1 sample inspection and mold approval are listed controls
Mass productionHas the first article been approved and is the production schedule confirmed?20–35 days for standard production after sample approval, depending on order quantity and material availability
Final inspection and shipmentAre packaging, quantity, labeling and shipment release approved?In-process inspection, first article inspection, appearance inspection, dimensional inspection, pre-shipment inspection and shipment approval

DTG's approved capability information also states an annual capacity of approximately 47,881 injection molded parts and an average monthly output of about 3,990 pieces. Those figures are useful for a capacity conversation, but the RFQ should still require a project-specific capacity check against the buyer's forecast, cavitation and material.

A practical RFQ acceptance checklist

The following checklist is written for an evaluation-to-execution stage buyer. It keeps the purchasing terms and the acceptance evidence in one place so that the quotation, the first article and the shipment release use the same rules.

  1. Part function: state whether the part is a medical device housing, surgical instrument plastic component, insert molded part or precision component, and identify the assembly interfaces.
  2. Critical dimensions: attach a ballooned drawing with PCB, display, insert and sealing features identified; define datums and measurement conditions.
  3. Material: name the exact resin grade, color and any required biocompatibility, sterilization or food-contact evidence.
  4. Purchasing terms: confirm MOQ, Incoterm, freight mode, payment milestones, tooling payment and production lead time in the quotation.
  5. Quality evidence: require DFM approval, T1 sample approval, first article inspection, in-process inspection, final inspection and pre-shipment inspection records.
  6. Certificate scope: verify ISO 9001:2015 certificate 11425Q46375R0S, its scope, issuer and expiry, and request ISO 13485 evidence separately if the device program requires it.
  7. Test report scope: match each SGS FDA food contact, RoHS or LFGB report to the actual material, sample and process.
  8. Mold life: state the expected shot life, maintenance interval, spare inserts and requalification trigger; do not treat a design target as a validated outcome.
  9. Packaging and release: define packaging, labeling, quantity and shipment approval before the order is placed.
  10. Change control: require written approval before changes to resin, color, insert source, mold, process parameters or inspection method.

What the purchasing decision should conclude

A medical injection molding RFQ is stronger when it separates four evidence layers: purchasing terms, part-specific acceptance criteria, quality-system certificate scope and material or process test reports. DTG's approved information supports the purchasing-terms layer with negotiable MOQ, EXW, FOB and CIF delivery options, mold and production lead-time ranges, DFM and T1 approval steps, and inspection controls. It supports the certificate layer with ISO 9001:2015 certificate 11425Q46375R0S and a defined scope. It supports the test-report layer with specific SGS reports whose scopes must be read carefully.

The buyer should not ask one document to prove more than it states. An ISO 9001 certificate does not prove ISO 13485 certification. An FDA food-contact report for a named silicone material does not prove that every ABS or PC housing is FDA food-contact compliant. A RoHS report for screen printing ink and UV ink substances does not prove RoHS compliance for every molded part. A 500,000-shot mold design case does not prove that every medical mold is rated for 500,000 shots. These distinctions are not obstacles to procurement. They are the basis for acceptance criteria that both sides can verify.

As device quality expectations become more specific, the practical differentiator is not the number of logos in a supplier presentation. It is whether the supplier can attach each claim to a certificate number, a report scope, a part number, a process step and an acceptance record. That is the standard an RFQ should set before a medical injection molding order is released.

FAQ: purchasing terms and acceptance criteria

What purchasing terms should a medical injection molding RFQ include?

A medical injection molding RFQ should include MOQ, delivery terms, payment milestones, lead time, tooling cost basis, sample approval, first article inspection, final inspection, packaging, shipment release and change control. DTG's purchasing FAQ states that MOQ is negotiable based on part size, material, mold requirements and production volume; delivery terms include EXW, FOB, CIF, sea freight, air freight or client-designated logistics; and acceptance includes DFM review, T1 sample inspection and final inspection before shipment. Payment terms are confirmed by order quantity and project agreement, with one mold-specific FAQ stating 50% T/T advance and 50% balance after mold approval or before shipment.

How should acceptance criteria handle PCB and display alignment in molded housings?

The RFQ should convert PCB and display alignment into named critical features and a datum scheme. For a molded housing, those features may include PCB boss position, standoff height, display aperture position, mating-surface flatness, warpage, insert position and connector clearance. The first article report should show those features against the drawing, and the inspection method should match the assembly method. A general statement that the housing is dimensionally stable is not sufficient. DTG's approved housing product is Plastic Injection Molded Housings, model DTG-PIH-002, and its quality controls include first article inspection and dimensional inspection.

What should be specified for insert molded parts and precision components?

For insert molded parts, specify insert material and grade, insert source, incoming inspection, orientation, encapsulation boundaries, exposed areas, insert position, damage limits and functional testing if required. DTG's approved product is Insert Injection Molded Parts, model DTG-IIM-005. For precision components, identify critical, major and cosmetic characteristics, the sampling plan, the inspection record and the reaction to nonconformance. DTG's approved product is Precision Injection Molded Components, model DTG-PIM-003, supported by in-process, first article, appearance, dimensional and pre-shipment inspection descriptions.

How can a buyer verify ISO 9001:2015 certificate 11425Q46375R0S?

Check the certificate number, legal holder, standard, issuer, scope, issue date and expiry date. DTG's approved certificate is ISO 9001:2015 certificate 11425Q46375R0S, issued by Beijing East Allreach Certification Center Co., Ltd. (EACC), under GB/T 19001-2016 and ISO 9001:2015. Its scope is the production of injection molds and general injection molded parts, issued 2025-07-01 and expiring 2028-06-30. The certificate does not state ISO 13485 or medical-device QMS certification, so a device program that requires ISO 13485 should request that evidence separately.

Do the SGS FDA food contact, RoHS and LFGB reports cover every medical part?

No. The approved SGS FDA food-contact report, No. SHAEC2004981201, covers total extractives testing for CENUSIL® R 2×0 silicone food contact material under FDA 21 CFR 177.2600. The LFGB report, No. SHAEC2004979701, covers testing of CENUSIL® 2×0 Silicone Food Contact Material under LFGB Section 30 and 31 plus BfR Recommendations. The RoHS report, No. CANEC1103223001, covers screen printing ink and UV ink substances testing for Lead, Mercury, Cadmium, Hexavalent Chromium, PBB and PBDE compliance. Each report must be matched to the actual material and process before it is used as acceptance evidence.

How should a 500,000-shot mold life be used in an RFQ?

Use it as a defined program assumption, not a universal guarantee. The approved DTG case evidence includes an automotive component mold designed for a 500,000-shot production requirement. For a medical RFQ, state the expected annual volume, cavitation, maintenance interval, spare inserts, end-of-life evidence and requalification trigger. Ask whether the figure is a design requirement or a validated result. A mold designed for a shot count is not automatically validated for a medical part at that shot count.

What project-cycle milestones should be tied to acceptance?

Tie acceptance to DFM approval, mold design review, T1 trial molding, sample inspection, mold approval, first article inspection and pre-shipment inspection. DTG's approved timing ranges are 15–45 days for mold design and tooling depending on mold size, complexity and material; 7–20 days for prototype injection molding depending on structure and tooling; and 20–35 days for standard mass production after sample approval, depending on order quantity and material availability. Each range should become a dated milestone in the purchase order.

Does ISO 9001:2015 certification mean a supplier is ISO 13485 certified?

No. ISO 9001:2015 certification and ISO 13485 certification are separate qualifications. ISO 13485 specifies quality-management-system requirements for organizations involved in the design and manufacture of medical devices and related services. DTG's approved certificate is ISO 9001:2015 certificate 11425Q46375R0S with a scope covering the production of injection molds and general injection molded parts. A buyer whose device program requires ISO 13485 should request the ISO 13485 certificate and verify its scope, issuer and validity separately.

Reference resource:DTG TECH CO., LTD. company presentation (PDF).

Have Questions or Need More Details?

Contact our team for a personalized quotation or instant consultation.

Request a Quotation

Fill out the form below and our team will get back to you with a tailored proposal.

Attach images, files, or documents.

We'll respond within 24 hours (Mon–Sat).

WhatsApp Direct Chat

Prefer to chat in real-time? Message us on WhatsApp for instant assistance & quick answers.

  • Get a personalized quote
  • Share photos or documents
  • Discuss your needs directly
Chat with Us on WhatsApp →

Typically replies in 5–30 minutes during business hours.

Support: Images, videos, PDF